Glow / Endo Health review

Glow is worth understanding as two purchases: an AI wellness app and a prescription program facilitated by Endo Health. The published medication introduction is useful, but the ongoing charge, dose, pharmacy and refund responsibility matter more than the first-month headline. Get those terms in writing before entering a recurring clinical plan.

Glow is an AI wellness-coaching brand operated by Endo Health, Inc. Its homepage also advertises an Endo Health GLP-1 clinical program and explicitly says that program has its own enrollment and billing. The Glow AI Coach app is purchased separately through Apple or Google Play.

Prescription-specific terms identify Endo Health as a facilitator, with medical services provided by independently licensed healthcare providers. The company is not presented as the treating medical practice or dispensing pharmacy. That distinction matters when deciding who can answer a prescribing question, change a prescription or process a medication refund. The public terms do not identify the legal practice assigned to an individual patient. A founder profile or an app response does not establish who will treat you.

The advertised prescription process is an online health questionnaire, clinician review or telehealth consultation, a prescription if appropriate, and pharmacy shipment. The homepage describes video or asynchronous consultation; it also advertises review within 24 hours. That is an advertised turnaround, rather than a guaranteed approval or delivery time. Prescription terms require users to be at least 18, reside in a supported state, provide identification and accurate health information, and meet clinical requirements. Completing an assessment does not guarantee a prescription.

The AI coach is a separate wellness tool: the site says it should not be used for medication management or dosing decisions. A question about side effects, suitability or a prescription change belongs with the treating clinician, not an assumption that the app is the clinical service.

The clinical homepage advertises compounded semaglutide at $99 for the first month and $199 per month afterward, and compounded tirzepatide at $199 initially and $349 per month afterward. Its FAQ also says pricing varies by medication and dosage. These are advertised introductory and ongoing amounts, not a confirmed quote for every prescribed dose. The page lists consultation, medication, shipping and ongoing support together; prescription terms say the displayed service price includes consultation fees, medication costs and shipping/handling. No insurance is accepted under those terms, and payment is due when the order is placed. Confirm the actual supply period, dose-specific charge and any split between merchant and pharmacy before paying.

The AI coach is purchased separately through Apple or Google Play. The homepage directs readers to the app for current subscription prices. A clinical enrollment should not be assumed to include the app subscription or vice versa. If both are selected, ask which payment account controls each renewal.

The prescription section labels its products compounded semaglutide and compounded tirzepatide with B6/B12 wording. That label does not establish the exact additive, concentration or quantity on a particular prescription. Ask for the selected formulation and the pharmacy label rather than assuming both vitamins or a particular vial size.

The homepage names Epiq Scripts in Texas and CraftedRx in Missouri as pharmacy partners, and the prescription terms direct medication-refund questions to those pharmacies. This identifies published relationships; it does not verify registrations independently or guarantee which partner fills an individual order.

The site states that compounded medicines are not FDA-approved. Its app features, testimonials and introductory price do not establish that a compounded product has the evidence, approval or manufacturing characteristics of a branded medicine.